Biocon Shares Slump 2% as USFDA Issues 5 Observations
April 30, 2026April 30, 2026 Shares of Biocon Ltd fell 2% during the early trading hours on Thursday, 30 April, after the company announced that the US drug regulator had issued a Form 483 with five observations for its biosimilars site in Bengaluru. Biocon stated that the US Food…